Top 20 of Hypertrophy, Left Ventricular

Article title # Publications/# Citations

Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

2006: CREATE Investigators; HUBurger; NClyne; TBDrueke; KUEckardt; FLocatelli; ICMacdougall; AScherhag; DTsakiris;

191

FGF23 induces left ventricular hypertrophy.

2011: RAguillon-Prada; APAmaral; MBrand; JChen; GSDi Marco; CFaul; HIFeldman; MFischer; ... CGadegbeku; ASGo; OMGutiérrez; JMHare; JAHill; MCHu; TIsakova; MGKeane; DKentrup; MKuro-O; JWKusek; JLincoln; OWMoe; AMorales; PMundel; LNessel; AOjo; BOskouei; SReuter; SERosas; JScialla; ASloan; EZSoliman; MSt John Sutton; KTiemann; RRTownsend; MWolf;

174

The progression from hypertension to congestive heart failure.

1996 May 22-29: KKHo; WBKannel; MGLarson; DLevy; RSVasan;

165

Impact of aortic stiffness on survival in end-stage renal disease.

1999: JBlacher; APGuérin; GMLondon; SJMarchais; BPannier; MESafar;

162

Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.

2002: LABarouch; DEBerkowitz; ALBurnett; TPCappola; JMHare; RWHarrison; IAHobai; PLHuang; ... ZAKobeissi; CALemmon; JALima; BO'Rourke; ERRodriguez; GORosas; MWSkaf;

137

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.

2000: MAikawa; ADucharme; SFrantz; RAKelly; RTLee; PLibby; MLindsey; ERabkin; ... LERohde; FJSchoen; ZWerb;

133

Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

1992: MHAlderman; SRDaniels; Ode Divitiis; Gde Simone; RBDevereux; RAMeyer; MJRoman;

132

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

1995: DEBild; JMFlack; JMGardin; SSGidding; TTKurosaki; BJMaron;

125

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.

2008: PBarenbrug; EECreemers; RFDuisters; VHerias; SHeymans; JJLeenders; VLentink; JGMaessen; ... YMPinto; MWSchellings; BSchroen; AJTijsen; Ivan der Made; REvan Leeuwen;

119

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

2009: RChristenson; ECoglianese; GCollerone; CDeFilippi; OMGutiérrez; UHoffmann; TIsakova; JLJanuzzi; ... KLaliberte; ASarwar; KSmith; TJWang; MWolf;

117

Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

2002: NGBellenger; PCollins; FGrothues; HUKlein; JCMoon; DJPennell; GCSmith;

116

Nephron number in patients with primary hypertension.

2003: KAmann; GKeller; GMall; ERitz; GZimmer;

115

Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

2009: CPAppleton; AEvangelisa; FAFlachskampf; TCGillebert; PNMarino; SFNagueh; JKOh; PAPellikka; OASmiseth; ADWaggoner;

104

Is the failing heart energy starved? On using chemical energy to support cardiac function.

2004: JSIngwall; RGWeiss;

103

Hypertrophy of the heart: a new therapeutic target?

2004: NFrey; JAHill; HAKatus; ENOlson;

102

ECM remodeling in hypertensive heart disease.

2007: BCBerk; KFujiwara; SLehoux;

96

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

2007: GFBaxter; PFerdinandy; RSchulz;

92

The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

2008: DABluemke; GLBurke; ARFolsom; RAKronmal; JALima; KLiu; JOlson;

92

Diabetic cardiomyopathy: the search for a unifying hypothesis.

2006: PParikh; IGPoornima; RPShannon;

89

Blood pressure as a cardiovascular risk factor: prevention and treatment.

1996 May 22-29: WBKannel;

84